Since 2014, Metabiota has been a partner of [[Peter Daszak]]’s EcoHealth Alliance and the [[Wuhan Institute of Virology]] as part of the [[U.S. Agency for International Development]]’s (USAID) “PREDICT” project, which seeks to “predict and prevent global emerging disease threats.” As part of this effort, researchers from Metabiota, EcoHealth Alliance, and the Wuhan Institute of Virology collaborated on a study relating to bat infectious diseases in China. “Sensitive and broadly reactive RT-PCR assays were performed at Wuhan Institute of Virology, Chinese Academy of Sciences,” the paper notes. Among the researchers listed is [[Shi Zhengli]], the Wuhan lab director. Peter Daszak is also listed as an author. | Since 2014, Metabiota has been a partner of [[Peter Daszak]]’s EcoHealth Alliance and the [[Wuhan Institute of Virology]] as part of the [[U.S. Agency for International Development]]’s (USAID) “PREDICT” project, which seeks to “predict and prevent global emerging disease threats.” As part of this effort, researchers from Metabiota, EcoHealth Alliance, and the Wuhan Institute of Virology collaborated on a study relating to bat infectious diseases in China. “Sensitive and broadly reactive RT-PCR assays were performed at Wuhan Institute of Virology, Chinese Academy of Sciences,” the paper notes. Among the researchers listed is [[Shi Zhengli]], the Wuhan lab director. Peter Daszak is also listed as an author. |